Telnivoc-M 500 Tablets

Telnivoc-M 500 is a combination anti-diabetic formulation containing Teneligliptin and Metformin Hydrochloride (Extended Release).

• Teneligliptin is a DPP-4 inhibitor that helps increase insulin secretion and reduce glucose production.

• Metformin Hydrochloride ER helps control high blood sugar by improving insulin sensitivity and reducing glucose absorption from the gut.
  This dual-action therapy is ideal for type 2 diabetes patients where diet and exercise alone are insufficient for glycaemic control.

Benefits:

• Helps in effective control of blood sugar levels in type 2 diabetes.

• Supports beta-cell function and enhances insulin release.

• Reduces post-meal and fasting glucose levels.

• Extended-release formulation for long-lasting effect and better patient compliance.

• Minimises risk of hypoglycaemia compared to some other anti-diabetic drugs.

Dosage:

• Adults: Usually 1 tablet once or twice daily, as prescribed by a physician.

Why Cardiever?

• GMP & ISO Certified Manufacturing ensuring premium quality.

• Clinically tested formulations for maximum efficacy and safety.

• Strict quality control at every stage of production.

• Trusted brand among healthcare professionals for innovative and reliable medicines.